Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

PHASE2CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Adult ADHD
Interventions
DRUG

AZD1446

10 mg capsule, oral dose

DRUG

AZD1446

80 mg capsule, oral dose

DRUG

AZD1446

80 mg capsule, oral dose

DRUG

Placebo

Matching capsule, oral dose

Trial Locations (6)

Unknown

Research Site, Los Alamitos

Research Site, Fort Myers

Research Site, New York

Research Site, Austin

Research Site, Burlington

Research Site, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY